RadiotherapyOligometastasesEstradiolBilateralProphylacticMastectomyBiopsyER-BreastTomosynthesisBOCAACChemotherapyFISHHormoneReplacementTherapyRelapseTamoxifenPrecisionMedicinePhyllodesTumorER+NodeNegative5-FluorouracilMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDown-StagingSelf-examinationMetastasisAngiogenesisCyclophosphamideTriplePositiveBreastCancerEGFR(epidermalgrowth factorreceptor)Estimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCAMCytostaticDefinitiveSurgeryCheckpointInhibitorCytotoxicAntibodyTherapyMastodyniaDoseDenseTherapyNodePositiveOophorectomyDisease-FreeSurvivalRateGenomicTestingSclerosingAdenosisAlopeciaKappaEpsilonBRCAGeneChemopreventionGermlineMutationlatissimusflapCalcificationsMastitisDiabeticMastopathyAxillarySamplingCachexiaAntiemeticPathologicResponseFlowCytometryGeneticPredispositionAromataseInhibitorsRADGeneticCounselingHerceptinNeoplasmCapecitabineApoptosisStagingBI-RADSMultifocalTumorsChemotherapyRaloxifeneBrachytherapyLumpectomyAyurvedaTumorGradeLapatinibAdjuvantTherapyMastalgiaCo-survivorSERMLiquidBiopsyHER-2CystMastectomyBreastCancerMolecularBreastImagingProgestinAdenocarcinomaCMFChemotherapyPI3KinaseInhibitorsPaclitaxelAnastrozolePalpationIntraductalPapillomaHormoneReceptorStatus1 in 8womenImmunotherapyTripleNegativeBreastCancerMethotrexateGuaranteedRenewableInsuranceBenignPhyllodesTumorLumpmTORInhibitorsInvasiveBreastCancerOvarianSuppressionECOGScoreMultimodalityTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.In-situCarcinomaLymphoscintigraphyKi-67RateExcisionalBiopsyWomen ages40+ shouldhave a clinicalbreast examat least yearlyLymphNodeStatusEstrogenTyrosine-KinaseInhibitorEndometrialCancerGeneMutationFamilyHistoryNeoadjuvantTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoxorubicinAdvocacyPalbociclibBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GailModelPARPInhibitorsBevacizumabMRILCISCDK4/6InhibitorsFibroadenomaPagetDiseaseDimplingAbsoluteRiskEvidencesuggests thatphysical activitymay reduce therisk of breastcancersDocetaxelMegestrolAcetateAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMorpheaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MetastaticBreastCancerRadiotherapyOligometastasesEstradiolBilateralProphylacticMastectomyBiopsyER-BreastTomosynthesisBOCAACChemotherapyFISHHormoneReplacementTherapyRelapseTamoxifenPrecisionMedicinePhyllodesTumorER+NodeNegative5-FluorouracilMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDown-StagingSelf-examinationMetastasisAngiogenesisCyclophosphamideTriplePositiveBreastCancerEGFR(epidermalgrowth factorreceptor)Estimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCAMCytostaticDefinitiveSurgeryCheckpointInhibitorCytotoxicAntibodyTherapyMastodyniaDoseDenseTherapyNodePositiveOophorectomyDisease-FreeSurvivalRateGenomicTestingSclerosingAdenosisAlopeciaKappaEpsilonBRCAGeneChemopreventionGermlineMutationlatissimusflapCalcificationsMastitisDiabeticMastopathyAxillarySamplingCachexiaAntiemeticPathologicResponseFlowCytometryGeneticPredispositionAromataseInhibitorsRADGeneticCounselingHerceptinNeoplasmCapecitabineApoptosisStagingBI-RADSMultifocalTumorsChemotherapyRaloxifeneBrachytherapyLumpectomyAyurvedaTumorGradeLapatinibAdjuvantTherapyMastalgiaCo-survivorSERMLiquidBiopsyHER-2CystMastectomyBreastCancerMolecularBreastImagingProgestinAdenocarcinomaCMFChemotherapyPI3KinaseInhibitorsPaclitaxelAnastrozolePalpationIntraductalPapillomaHormoneReceptorStatus1 in 8womenImmunotherapyTripleNegativeBreastCancerMethotrexateGuaranteedRenewableInsuranceBenignPhyllodesTumorLumpmTORInhibitorsInvasiveBreastCancerOvarianSuppressionECOGScoreMultimodalityTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.In-situCarcinomaLymphoscintigraphyKi-67RateExcisionalBiopsyWomen ages40+ shouldhave a clinicalbreast examat least yearlyLymphNodeStatusEstrogenTyrosine-KinaseInhibitorEndometrialCancerGeneMutationFamilyHistoryNeoadjuvantTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoxorubicinAdvocacyPalbociclibBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GailModelPARPInhibitorsBevacizumabMRILCISCDK4/6InhibitorsFibroadenomaPagetDiseaseDimplingAbsoluteRiskEvidencesuggests thatphysical activitymay reduce therisk of breastcancersDocetaxelMegestrolAcetateAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMorpheaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MetastaticBreastCancer

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Radiotherapy
  2. Oligometastases
  3. Estradiol
  4. Bilateral Prophylactic Mastectomy
  5. Biopsy
  6. ER-
  7. Breast Tomosynthesis
  8. BOCA
  9. AC Chemotherapy
  10. FISH
  11. Hormone Replacement Therapy
  12. Relapse
  13. Tamoxifen
  14. Precision Medicine
  15. Phyllodes Tumor
  16. ER+
  17. Node Negative
  18. 5-Fluorouracil
  19. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  20. Down-Staging
  21. Self-examination
  22. Metastasis
  23. Angiogenesis
  24. Cyclophosphamide
  25. Triple Positive Breast Cancer
  26. EGFR (epidermal growth factor receptor)
  27. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  28. CAM
  29. Cytostatic
  30. Definitive Surgery
  31. Checkpoint Inhibitor
  32. Cytotoxic
  33. Antibody Therapy
  34. Mastodynia
  35. Dose Dense Therapy
  36. Node Positive
  37. Oophorectomy
  38. Disease-Free Survival Rate
  39. Genomic Testing
  40. Sclerosing Adenosis
  41. Alopecia
  42. Kappa Epsilon
  43. BRCA Gene
  44. Chemoprevention
  45. Germline Mutation
  46. latissimus flap
  47. Calcifications
  48. Mastitis
  49. Diabetic Mastopathy
  50. Axillary Sampling
  51. Cachexia
  52. Antiemetic
  53. Pathologic Response
  54. Flow Cytometry
  55. Genetic Predisposition
  56. Aromatase Inhibitors
  57. RAD
  58. Genetic Counseling
  59. Herceptin
  60. Neoplasm
  61. Capecitabine
  62. Apoptosis
  63. Staging
  64. BI-RADS
  65. Multifocal Tumors
  66. Chemotherapy
  67. Raloxifene
  68. Brachytherapy
  69. Lumpectomy
  70. Ayurveda
  71. Tumor Grade
  72. Lapatinib
  73. Adjuvant Therapy
  74. Mastalgia
  75. Co-survivor
  76. SERM
  77. Liquid Biopsy
  78. HER-2
  79. Cyst
  80. Mastectomy
  81. Breast Cancer
  82. Molecular Breast Imaging
  83. Progestin
  84. Adenocarcinoma
  85. CMF Chemotherapy
  86. PI3 Kinase Inhibitors
  87. Paclitaxel
  88. Anastrozole
  89. Palpation
  90. Intraductal Papilloma
  91. Hormone Receptor Status
  92. 1 in 8 women
  93. Immunotherapy
  94. Triple Negative Breast Cancer
  95. Methotrexate
  96. Guaranteed Renewable Insurance
  97. Benign Phyllodes Tumor
  98. Lump
  99. mTOR Inhibitors
  100. Invasive Breast Cancer
  101. Ovarian Suppression
  102. ECOG Score
  103. Multimodality Therapy
  104. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  105. In-situ Carcinoma
  106. Lymphoscintigraphy
  107. Ki-67 Rate
  108. Excisional Biopsy
  109. Women ages 40+ should have a clinical breast exam at least yearly
  110. Lymph Node Status
  111. Estrogen
  112. Tyrosine-Kinase Inhibitor
  113. Endometrial Cancer
  114. Gene Mutation
  115. Family History
  116. Neoadjuvant Therapy
  117. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  118. Doxorubicin
  119. Advocacy
  120. Palbociclib
  121. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  122. Gail Model
  123. PARP Inhibitors
  124. Bevacizumab
  125. MRI
  126. LCIS
  127. CDK4/6 Inhibitors
  128. Fibroadenoma
  129. Paget Disease
  130. Dimpling
  131. Absolute Risk
  132. Evidence suggests that physical activity may reduce the risk of breast cancers
  133. Docetaxel
  134. Megestrol Acetate
  135. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  136. Morphea
  137. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  138. Metastatic Breast Cancer